Saturday 17 October 2026
Export PAHC’s income statement to Excel — free account
Phibro Animal Health Corporation
PAHC Healthcare Drug Manufacturers Specialty & Generic
Phibro Animal Health Corporation’s revenue for fiscal 2026 (year ended June 2026) was $1.5 billion, up 17.1% from fiscal 2025. In the quarter to June 2026, revenue grew 4.77%, EPS grew 28.6%, free cash flow fell 35.7% and total debt rose 1.96%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
38.82
0.84
+2.21%
Follow PAHC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 29.72% | 30.34% | 31.80% | 23.79% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 7 | 7 | 5 | |
| 6.97% | 6.90% | 6.84% | 5.77% | ||
ROIC |
11.72% | 11.03% | 10.67% | 9.29% | |
Return on Tangible Assets |
10.09% | 9.80% | 9.85% | 7.37% | |
Average Days of Receivables |
57.41 | 53.91 | 53.81 | 56.82 | |
Free Cash Flow per Share |
0.24 | 0.31 | 1.17 | 0.85 | |
Free Cash Flow |
9.87 | 12.77 | 47.29 | 34.29 | |
Capital Expenditures |
(59.09) | (53.36) | (45.79) | (42.52) | |
| Other line items | |||||
Cash ROIC |
0.82% | 1.09% | 4.16% | 3.01% | |
Accounts Receivable Turnover |
6.50 | 7.16 | 7.18 | 7.39 | |
Accounts Payable Turnover |
7.57 | 7.75 | 8.57 | 8.87 | |
Inventory Turnover |
2.05 | 2.05 | 2.11 | 2.59 | |
Average Days of Payables |
46.21 | 46.76 | 48.78 | 49.48 | |
Days of Inventory on Hand |
194.15 | 194.67 | 189.34 | 178.73 | |
Tax Rate |
(0.27) | (0.26) | (0.27) | (0.28) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.96% | 20.54% | 20.36% | 20.88% | |
Share Based Compensation of Revenue |
0.11% | 0.09% | 0.08% | 0.06% | |
Interest Coverage |
4.38 | 4.20 | 4.04 | 3.69 | |
Operating CF/Net income |
0.69 | 0.69 | 1.01 | 1.13 | |
Depreciation/Fixed assets |
0.15 | 0.15 | 0.15 | 0.15 | |
Capex/Depreciation |
(1.10) | (1.01) | (0.86) | (0.82) | |
Revenue per Share |
37.44 | 36.99 | 36.13 | 34.53 | |
Operating CF per Share |
1.70 | 1.63 | 2.30 | 1.89 | |
Capex per Share |
(1.46) | (1.32) | (1.13) | (1.05) | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.03 |
Columns are period end dates